To visualize these global relationships, we generated comprehensive heatmaps showing the efficacy and synergy responses of all 87 anti-cancer drugs screened in combination with six ATM/ATR/DNA-PK inhibitors across all 62 cell lines and 12 tissues (Fig. 1b and Supplementary Figs. 1–3). Here, PRKDC is linked to cancer.